Medicare Enrolled

Dr. Jeffrey Kozlowski, MD

Nephrology · Midland Park, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Mixed engagement
44 GODWIN AVE, Midland Park, NJ 07432
2014470013
In practice since 2005 (20 years)
NPI: 1558352369 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kozlowski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kozlowski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kozlowski

Dr. Jeffrey Kozlowski is a nephrology specialist in Midland Park, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kozlowski performed 100 Medicare services across 82 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kozlowski received a total of $7,602 from 34 pharmaceutical and/or device companies across 229 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kozlowski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 100 Medicare services $7,602 industry payments

Medicare Practice Summary

Medicare Utilization ↗
100
Medicare services
Bottom 4% in NJ for nephrology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
82
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 85 $60 $103
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 15 $103 $157
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,602
Total received (2018-2024)
Avg $1,086/year across 7 years
Top 9% in NJ for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
229
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,975 (39.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,915 (38.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,711 (22.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18
2023
$16
2022
$531
2021
$2,116
2020
$3,330
2019
$899
2018
$692

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Fresenius USA Marketing, Inc.
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,098
Otsuka Pharmaceutical Development & Commercialization, Inc.
$1,711
Otsuka America Pharmaceutical, Inc.
$578
Relypsa, Inc.
$388
OPKO Pharmaceuticals, LLC
$370
Amgen Inc.
$205
Vifor Pharma, Inc.
$203
AKEBIA THERAPEUTICS INC
$198
Bayer HealthCare Pharmaceuticals Inc.
$112
Fresenius USA Marketing, Inc.
$84
Mallinckrodt Hospital Products Inc.
$59
Mallinckrodt LLC
$57
Horizon Therapeutics plc
$57
Lundbeck LLC
$55
Mallinckrodt Enterprises LLC
$42
Strongbridge US INC.
$40
Allergan Inc.
$39
Alexion Pharmaceuticals, Inc.
$39
Exeltis, USA Inc.
$35
Amarin Pharma Inc.
$29
ARBOR PHARMACEUTICALS, INC.
$25
Aurinia Pharma U.S., Inc.
$20
CALLIDITAS THERAPEUTICS US INC.
$18
Travere Therapeutics, Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
Cumberland Pharmaceuticals, Inc.
$14
Janssen Pharmaceuticals, Inc
$13
GlaxoSmithKline, LLC.
$12
Daiichi Sankyo Inc.
$12
Genentech USA, Inc.
$12
Endo Pharmaceuticals Inc.
$12
Mission Pharmacal Company
$12
Keryx Biopharmaceuticals, Inc.
$11
Top 3 companies account for 70.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · AURYXIA · Auryxia · BENLYSTA · BYSTOLIC · Edarbi · FARXIGA · INJECTAFER · INVOKANA · JYNARQUE · KEVEYIS · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · NASCOBAL · NORTHERA · Not Product Related · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · Rituxan · SAMSCA · SOLIRIS · TARPEYO · Urocit-K · Vaprisol · Vascepa · Velphoro · Veltassa · Venofer · WATCHMAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (39%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for nephrology in NJ.

Looking for a nephrology specialist in Midland Park?
Compare nephrologists in the Midland Park area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
552
Per 100K population
57.8
County median income
$123,715
Nearest hospital
RAMAPO RIDGE BEHAVIORAL HEALTH HOSPITAL
1.5 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kozlowski is a clinical cardiology specialist, with moderate Medicare volume, with mixed engagement industry engagement in the top 9% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kozlowski experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Kozlowski performed 85 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kozlowski receive payments from pharmaceutical companies?
Yes. Dr. Kozlowski received a total of $7,602 from 34 companies across 229 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kozlowski's costs compare to other nephrologists in Midland Park?
Dr. Kozlowski's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kozlowski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Midland Park
Browse nephrologists in Midland Park ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in NJ
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in NJ
Which NJ nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Otsuka Pharmaceutical Development & Commercialization, Inc. Payments to Doctors
See all physicians who received payments from Otsuka Pharmaceutical Development & Commercialization, Inc.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →